Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.683 SEK | -1.59% | -5.01% | -6.44% |
Feb. 20 | Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Feb. 20 | Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 3
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Arfolitixorin
100.0
%
| 13 | 100.0 % | 1 | 100.0 % | -94.37% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Asia
100.0
%
| 13 | 100.0 % | 1 | 100.0 % | -94.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Petter Lindqvist
CEO | Chief Executive Officer | 72 | Jan. 08 |
Magnus Hurst
DFI | Director of Finance/CFO | 68 | Jan. 09 |
Roger Tell
CTO | Chief Tech/Sci/R&D Officer | 59 | 19-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lars Erik Lind
CHM | Chairman | 83 | - |
Sten Nilsson
BRD | Director/Board Member | 76 | Jan. 03 |
Alain Herrera
BRD | Director/Board Member | 74 | 17-12-31 |
Chairman | 79 | 23-02-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 161,515,440 | 101,064,675 ( 62.57 %) | 0 | 62.57 % |
Company contact information
Isofol Medical AB
Biotech Center Arvid Wallgrens Backe 20
413 46, Gothenburg
+46 3 17 97 22 80
http://www.isofol.seSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-6.44% | 10.22M | |
+4.06% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B | |
+3.90% | 1.65B |
- Stock Market
- Equities
- ISOFOL Stock
- Company Isofol Medical AB